| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,587,922 | 2,316,880 | 2,157,876 | 2,094,165 | | Cost of Revenue | 2,164,967 | 1,923,122 | 1,789,585 | 1,756,490 | | | Gross Profit | 422,955 | 393,758 | 368,291 | 337,675 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 347,968 | 327,552 | 313,002 | 314,487 | | Non Recurring |
-
|
-
|
-
| 643,459 | | Others | 14,011 | 13,771 | 12,872 | 12,697 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 60,976 | 52,435 | 42,417 | (632,968) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (9,908) | 14,494 | (4,065) |
-
| | Earnings Before Interest And Taxes | 58,604 | 70,395 | 39,066 | (629,777) | | Interest Expense | 15,775 | 40,253 | 13,153 | 29,025 | | Income Before Tax | 42,829 | 30,142 | 25,913 | (658,802) | | Income Tax Expense | 15,033 | 10,309 | 9,717 | (155,652) | | Minority Interest | (247) |
-
|
-
| (81) | | | | Net Income From Continuing Ops | 27,796 | 19,833 | 16,196 | (503,231) | | | Non-recurring Events | | Discontinued Operations | (134) | (5,666) | 6 | (6,679) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,415 | 14,167 | 16,202 | (509,910) | | Preferred Stock And Other Adjustments | 8 | (88) | 80 |
-
| | | Net Income Applicable To Common Shares | $27,423 | $14,079 | $16,282 | ($509,910) |
|
1.00% Nasdaq 0.00%
Income Statement
